Fact CheckerSign in

NCT06849505Recruiting

Transcranial Magnetic Stimulation Synchronized with Motor Task Training for Post-Stroke Rehabilitation

Closed - Loop Neuromodulation of Post - Stroke Motor Dysfunction by Transcranial Magnetic Stimulation Synchronized with Specific Motor Task Training

Source: ClinicalTrials.gov · Last updated 27 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this clinical trials is to investigate the effectiveness of individualized online repetitive transcranial magnetic stimulation (rTMS) in enhancing upper limb motor rehabilitation during the subacute and chronic phase of stroke. It will also learn about the safety of individualized online rTMS intervention methods. The main questions it aims to answer are: Does rTMS synchronized with motor training improve motor rehabilitation in patients with the ability to induce motor evoked potentials(MEPs)? Dose individualized rTMS synchronized with motor training improve motor rehabilitation in patients without the ability to induce MEPs? Researchers will compare online rTMS to offline and sham stimulation in patients with MEPs to see if online rTMS works to alleviate motor dysfunction in preliminary trials. And compare individualized online rTMS to non-individualized online rTMS and sham in patients without MEPs to see if individualized online rTMS works to alleviate motor dysfunction in Randomized, double-blinded, and controlled trials. Participants will: randomized to one group acoording to the MEP condition of each person; receive rTMS treatment for 10 days, with 5 working days per week for a total of two weeks; receive magnetic resonance imaging (MRI) and electroencephalogram (EEG) evaluations before and after the entire treatment; conduct scales and MEP assessment one day before the treatment, as well as one day, one month, and three months after the treatment.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
15 (estimated)
First submitted
19 Feb 2025
Start date
2 Jul 2024
Primary completion date
30 Jun 2025
Lead sponsor
First Affiliated Hospital of the Chinese People's Liberation Army Naval Medical University
Diseases
Stroke
NCT number
NCT06849505

What you commit to

  • Study type: Interventional
  • Planned participants: 15
  • From 2 Jul 2024 to the primary completion date, 30 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with severe heart, lung, liver, kidney diseases and malignant tumors;
  • Those with a history of aphasia, severe cognitive impairment or mental illness;
  • Patients who have had a history of epileptic seizures in the last month or are taking anti-epileptic drugs recently;
  • People with metal implants, pacemakers, skull defects or other conditions that prevent them from undergoing TMS.

Other

  • Those with severe visual or hearing impairments, unable to communicate normally;

Who the study is looking for

  • The patient is first diagnosed with stroke through neurological examination, CT or MRI scan.
  • The vital signs are stable and there is a certain degree of upper limb motor dysfunction.
  • The age is between 20 and 80 years old.
  • The cognitive ability is not significantly affected and the patient can cooperate with various examinations and assessments, with a MMSE score ≥ 20 points.
  • There are no serious complications (such as pneumonia, heart failure, urinary tract infection or malnutrition).
  • There is no pathological condition that is a contraindication for TMS in the medical history (for example, patients with metal in the brain, such as aneurysm clips, patients with a cardiac pacemaker, pregnant women, or those with a history of epileptic seizures).
  • The patient or guardian agrees to sign the informed consent form.

Age in the registry: 20 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
First Affiliated Hospital of the Chinese People's Liberation Army Naval Medical University
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.